⌘K

Login Start Free

Home/Filings/4/0001654954-19-010741

4//SEC Filing

OAKES FRANK R. 4

Accession 0001654954-19-010741

CIK 0001540159other

View on SEC.gov Company Profile

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:24 PM ET

Size

4.4 KB

Accession

0001654954-19-010741

Insider Transaction Report

Form 4

Period: 2019-09-11

Edesa Biotech, Inc.EDSA

DirectorPresident, CEO & Director

Transactions

Sale
Common Shares
2019-09-11$5.72/sh−1,809$10,345→ 6,165 total

Footnotes (1)

[F1]All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1

filerCIK 0001620188

Filing Metadata

Form type: 4
Filed: Sep 12, 8:00 PM ET
Accepted: Sep 13, 4:24 PM ET
Size: 4.4 KB

View on SEC.gov